IGF1 and breast cancer: Moreover, this study suggested that the crosstalk between the IGF-I axis and antitumor immune responses can mobilize pro-inflammatory cytokines, offering a new clinical approach for treatment of mammary tumors expressing IGF-IR (Durfort et al., 2012).